OnDemand WTP Pricing Research

GOP balks at Trump drug pricing plan | TheHill

Republican opposition is building to a proposal from President Trump to lower drug prices in Medicare.

The rare break between Trump and Republican allies follows an aggressive step from the president in October that would tie certain Medicare drug prices to lower prices in other countries, a departure from the traditional GOP position.

A coalition of conservative groups, including Americans for Tax Reform and FreedomWorks, on Tuesday wrote a letter calling for the proposal to be withdrawn. And on Thursday, House GOP lawmakers questioned Health and Human Services (HHS) Secretary Alex Azar about the move and aired their concerns in a private meeting.

Senate Finance Committee Chairman Orrin Hatch (R-Utah) is talking to other GOP senators about writing a letter to the administration sharing their concerns about the proposal.

A spokesperson for Sen. Chuck Grassley (R-Iowa), who will take over the committee’s gavel from Hatch in January, likewise told The Hill the Iowa senator has concerns Trump’s proposal would impose “price controls.”

Trump has long railed against drug companies and called for lowering prices. His controversial proposal on Medicare drug prices is his most sweeping move yet.

Trump administration officials argue the current Medicare payment system for drugs administered in doctors’ offices essentially lets drug companies charge whatever they want. They insist that system needs to change.

But critics worry the move is essentially importing price controls from other countries, which is anathema to free-market minded Republicans, who are pushing back.

“I understand that we do want to get drug prices down but I think that any proposal that would lead to government price-fixing in that space is a pathway we don’t want to follow,” Rep. Larry Bucshon

Read complete article here:

GOP balks at Trump drug pricing plan | TheHill.